High Macrophage Migration Inhibitory Factor (MIF) Serum Levels Associated with Extended Psoriasis
- 1 June 2001
- journal article
- Published by Elsevier in Journal of Investigative Dermatology
- Vol. 116 (6) , 989-990
- https://doi.org/10.1046/j.0022-202x.2001.01366.x
Abstract
No abstract availableKeywords
Funding Information
- Ministry of Education, Culture, Sports, Science and Technology
This publication has 9 references indexed in Scilit:
- Evidence for a role of macrophage migration inhibitory factor in psoriatic skin diseaseBritish Journal of Dermatology, 1999
- The Immunologic and Genetic Basis of PsoriasisArchives of Dermatology, 1999
- Sustained Mitogen-activated Protein Kinase (MAPK) and Cytoplasmic Phospholipase A2 Activation by Macrophage Migration Inhibitory Factor (MIF)Journal of Biological Chemistry, 1999
- Cytokines in psoriasisInternational Journal of Dermatology, 1999
- Ultraviolet B Radiation Upregulates the Production of Macrophage Migration Inhibitory Factor (MIF) in Human Epidermal KeratinocytesJournal of Investigative Dermatology, 1999
- Macrophage Migration Inhibitory Factor Is an Essential Immunoregulatory Cytokine in Atopic DermatitisBiochemical and Biophysical Research Communications, 1997
- MIF rediscovered: cytokine, pituitary hormone, and glucocorticoid‐induced regulator of the immune responseThe FASEB Journal, 1996
- Correlated increases of tumour necrosis factor-alpha, interleukin-6 and granulocyte monocyte-colony stimulating factor levels in suction blister fluids and sera of psoriatic patients relationships with disease severityClinical and Experimental Dermatology, 1994
- Interleukin-8 Stimulates Calcium Transients and Promotes Epidermal Cell ProliferationJournal of Investigative Dermatology, 1992